Resources from the same session
LBA24 - KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation
Presenter: Samuel Klempner
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Abstract
Slides
Webcast
315O - Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
Presenter: Yasutoshi Kuboki
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA24 and 315O
Presenter: Maria Elena Elez Fernandez
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Slides
Webcast
LBA25 - FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
Presenter: N. Arvind Dasari
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Abstract
Slides
Webcast
316O - Genomic mechanisms of acquired resistance of patients (pts) with BRAF V600E-mutant (mt) metastatic colorectal cancer (mCRC) treated in the BEACON study
Presenter: Scott Kopetz
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Slides
Webcast